Yong Xi

697 total citations
16 papers, 525 citations indexed

About

Yong Xi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yong Xi has authored 16 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yong Xi's work include Esophageal Cancer Research and Treatment (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Yong Xi is often cited by papers focused on Esophageal Cancer Research and Treatment (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Yong Xi collaborates with scholars based in China, Malaysia and Japan. Yong Xi's co-authors include Yu Gao, Lingli Chen, Yaping Li, Wangwen Gu, Liping Lin, Zhenghong Xu, Zhiwen Zhang, Jian Ding, Meiyu Geng and Yi Chen and has published in prestigious journals such as Biomaterials, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Yong Xi

14 papers receiving 516 citations

Peers

Countries citing papers authored by Yong Xi

Since Specialization

Citations

This map shows the geographic impact of Yong Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Xi more than expected).

Fields of papers citing papers by Yong Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Xi. The network helps show where Yong Xi may publish in the future.

Co-authorship network of co-authors of Yong Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Xi. A scholar is included among the top collaborators of Yong Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Xi. Yong Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Prognostic value and potential biological function of PMSD11 in lung adenocarcinoma 2024 ·Journal of Thoracic Disease ·Yong Xi, Jing Zeng, Yundong Zhou, Weiyu Shen, Hirokazu Taniguchi, Retnagowri Rajandram, Sivakumar Krishnasamy	0
2	Gut Microbiome Dysbiosis in Patients with Endometrial Cancer vs. Healthy Controls Based on 16S rRNA Gene Sequencing 2023 ·Current Microbiology ·Yue Li, Geng Liu, (unknown), Yong Xi	14
3	Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate 2023 ·Journal of Medicinal Chemistry ·Da-Qiang Li, Zhuo Zhang, Yalei Li, Xinyi Wang, (unknown), Huajie Yang, Yong Xi, Hong‐Chun Liu, Aijun Shen, Youhong Hu	11
4	Corni Fructus extracts ameliorate Streptozotocin-Induced diabetes in mice via regulating AMPK/ACC/CPT-1 signaling pathway 2023 ·Journal of Functional Foods ·Xiaolin Yang, Yujing Wang, (unknown), (unknown), (unknown), Jiefang Kang, Yong Xi, Xiaochang Xue	7
5	Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells 2020 ·BioMed Research International ·Yong Xi, Xin Nie, Jing Wang, Lingling Gao, (unknown)	5
6	A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma 2018 ·Journal of Thoracic Disease ·Weiyu Shen, Yaxing Shen, Lijie Tan, (unknown), Yong Xi	21
7	Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 2017 ·Molecular Cancer Therapeutics ·Jing Ai, Yi Chen, Peng Xia, Yinchun Ji, Yong Xi, Yanyan Shen, Xinying Yang, Yi Su, Yiming Sun, Yinglei Gao, Yuchi Ma, Bing Xiong, Jingkang Shen, Jian Ding, Meiyu Geng	26
8	Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors 2016 ·European Journal of Medicinal Chemistry ·Liu Yang, Peng Xia, (unknown), Dong Lu, Yong Xi, Shiyu Jin, Hui Chen, Limin Zeng, Jing Ai, Meiyu Geng, Youhong Hu	11
9	Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study 2015 ·European Journal of Medicinal Chemistry ·Xiaolong Jiang, Ji Zhou, Jing Ai, Zilan Song, Peng Xia, Xing Li, Yong Xi, Junfeng Guo, Qizheng Yao, Jian Ding, Meiyu Geng, Ao Zhang	15
10	Cervical triangulating anastomosis for minimally invasive esophagectomy (MIE) 2015 ·ASVIDE ·Jingpei Li, Yaxing Shen, Lijie Tan, Mingxiang Feng, Hao Wang, Yong Xi, (unknown), Qun Wang	0
11	Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation 2015 ·Oncotarget ·Jie Zhang, Pengxing He, Yong Xi, Meiyu Geng, Yi Chen, Jian Ding	52
12	AL3810, a multi‐tyrosine kinase inhibitor, exhibits potent anti‐angiogenic and anti‐tumour activity via targeting VEGFR, FGFR and PDGFR 2012 ·Journal of Cellular and Molecular Medicine ·Yuanfeng Zhou, Yi Chen, Linjiang Tong, Hua Xie, Weiwei Wen, Jie Zhang, Yong Xi, Yanyan Shen, Meiyu Geng, Yuanyuan Wang, Hualiang Jiang, Cheng Luo, Liping Lin, Jian Ding	24
13	The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma 2008 ·Biomaterials ·Zhenghong Xu, Lingli Chen, Wangwen Gu, Yu Gao, Liping Lin, Zhiwen Zhang, Yong Xi, Yaping Li	245
14	Targeted Nanoassembly Loaded with Docetaxel Improves Intracellular Drug Delivery and Efficacy in Murine Breast Cancer Model 2008 ·Molecular Pharmaceutics ·Yu Gao, Lingli Chen, Wangwen Gu, Yong Xi, Liping Lin, Yaping Li	49
15	Rule of oxygen transmission in dump leaching 2006 ·Journal of Central South University of Technology ·(unknown), Hongjiang Wang, (unknown), Baohua Yang, Yong Xi, (unknown)	1
16	11,11???-Dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity 2005 ·Anti-Cancer Drugs ·Yixiang Zhang, Yi Chen, Xiaoning Guo, Xiongwen Zhang, Weimin Zhao, Zhong Li, Jin Zhou, Yong Xi, Liping Lin, Jian Ding	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact